Understanding the earliest immune responses following HIV infection is critical to inform
future vaccines and therapeutics. Here, we review recent prospective human studies in at …

Antiretroviral therapy during the earliest stage of acute HIV infection (Fiebig I) might
minimize establishment of a latent HIV reservoir and thereby facilitate viremic control after …

Induction of broadly neutralizing antibodies (bnAbs) capable of inhibiting infection with
diverse variants of human immunodeficiency virus type 1 (HIV‐1) is a key, as‐yet …

There is a great need for the development of vaccines that induce potent and long-lasting
protective immunity against SARS-CoV-2. Multimeric display of the antigen combined with …

Schistosomiasis is a disease caused by parasitic flatworms of the Schistosoma spp., and is
increasingly recognized to alter the immune system, and the potential to respond to …

Early initiation of antiretroviral therapy (ART) in acute HIV infection (AHI) is effective at
limiting seeding of the HIV viral reservoir, but little is known about how the resultant …

Humoral immunity is a critical component of the coordinated response required to resolve
viral infections and mediate protection following pathogen clearance or vaccination. A better …

HIV latency is the main barrier to HIV eradication. Peripheral T follicular helper (pTfh) cells
have a prominent role in HIV persistence. Herein, we analyzed the HIV reservoir size within …

There are currently approximately 4000 mutations in the SARS-CoV-2 S protein gene and
emerging SARS-CoV-2 variants continue to spread rapidly worldwide. Universal vaccines …

T follicular helper cells (TFH) are a specialized subset of CD4 T cells that reside in B cell
follicles and promote B cell maturation into plasma cells and long-lived memory B cells …